Apex drugs regulator plans to up risk-based inspection, monitoring, sampling, enforcement to check spurious drugs Strengthening Drug Safety: India’s Apex Drugs Regulator Plans Risk-Based Inspections and Monitoring The Indian pharmaceutical landscape is renowned for its vast scale, contributing significantly to both domestic consumption and global exports. However, the specter of spurious drugs—counterfeit, substandard, or falsified medicines—poses a serious threat to public health. In a significant move to combat this menace, India’s apex drugs regulator has […]
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.